Evidence map›Paper›PMID 30484341›Full record

ReviewExpert opinion on therapeutic targets2019

The COX-2/prostanoid signaling cascades in seizure disorders.

Asheebo Rojas, Di Chen, Thota Ganesh, Nicholas H Varvel, Raymond Dingledine

Abstract readReview
In one paragraph

Review in Expert opinion on therapeutic targets, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. The potential role of COX-2/PGs signaling pathway in epileptogenesis and associated neuroinflammation: collusions or serendipity.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Therapeutic potential of COX-2 inhibitors in neuropsychiatric disorders.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Astrocyte-neuron circuits in epilepsy.Neurobiology of disease · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Asheebo Rojasa Department of Pharmacology , Emory University School of Medicine , Atlanta , GA , USA.
Di Chena Department of Pharmacology , Emory University School of Medicine , Atlanta , GA , USA.
Thota Ganesha Department of Pharmacology , Emory University School of Medicine , Atlanta , GA , USA.
Nicholas H Varvela Department of Pharmacology , Emory University School of Medicine , Atlanta , GA , USA.
Raymond Dingledinea Department of Pharmacology , Emory University School of Medicine , Atlanta , GA , USA.
Emory University · US

Funding

Development of EP2 receptor antagonists for suppression of Alzheimer's neuropathologyU01AG052460 · NIA · EMORY UNIVERSITY · PI GANESH, THOTA · 2016 to 2020
$3.9M
Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizuresR01NS097776 · NINDS · EMORY UNIVERSITY · PI DINGLEDINE, RAYMOND J · 2016 to 2020
$2.2M
EP2 antagonists as novel anti-epileptogenic agentsR21NS101167 · NINDS · EMORY UNIVERSITY · PI GANESH, THOTA · 2018 to 2019
$747k
EP2 antagonists as novel anti-epileptogenic agentsR33NS101167 · NINDS · EMORY UNIVERSITY · PI GANESH, THOTA · 2020 to 2020
$389k
NIA NIH HHS U01 AG052460NINDS NIH HHS R01 NS097776NINDS NIH HHS R21 NS101167NINDS NIH HHS R33 NS101167
6 · The paper itself

Abstract

Introduction:A robust neuroinflammatory response is a prevalent feature of multiple neurological disorders, including epilepsy and acute status epilepticus. One component of this neuroinflammatory reaction is the induction of cyclooxygenase-2 (COX-2), synthesis of several prostaglandins and endocannabinoid metabolites, and subsequent activation of prostaglandin and related receptors. Neuroinflammation mediated by COX-2 and its downstream effectors has received considerable attention as a potential target class to ameliorate the deleterious consequences of neurological injury. Areas covered: Here we describe the roles of COX-2 as a major inflammatory mediator. In addition, we discuss the receptors for prostanoids PGE

Indexed as

Molecular Targeted TherapyAnimalsBrainCyclooxygenase 2Cyclooxygenase 2 InhibitorsEpilepsyHumansInflammationProstaglandinsReceptors, ImmunologicReceptors, ProstaglandinReceptors, Prostaglandin ESignal TransductionCyclooxygenase 2Cyclooxygenase 2 Inhibitorsprostaglandin D2 receptorprostaglandin F2alpha receptorProstaglandinsReceptors, ImmunologicReceptors, ProstaglandinReceptors, Prostaglandin ECyclooxygenase-2endocannabinoidEP1EP2epilepsyepileptogenesisNSAIDprostaglandinsseizures

Identifiers

PMID30484341
PMCPMC6481174
OpenAlexW2903020810

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.